ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryOetwil An Der LimmatCuraxon AG
Curaxon AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Curaxon Ltd. is the development and marketing of innovative drugs for the treatment of neurodegenerative diseases of the central nervous system (CNS), particularly those with high medical need and insufficient therapeutic options. To this end, the company modifies existing active ingredients to improve their pharmacokinetic and pharmacodynamic properties and to exploit new mechanisms of action in order to achieve higher therapeutic efficacy.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered2
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Curaxon AG

Development of new medicines
Development of new medicines for neurodegenerative diseases with high medical need, in particular through chemical modification of existing active ingredients and new mechanisms of action.
Development of innovative therapies for central nervous system disorders
Innovative therapies for patients with central nervous system disorders, focusing on high therapeutic efficacy and improved pharmacokinetic and pharmacodynamic properties.
Trust & reputation

ranQ Trust Score of Curaxon AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

Curaxon AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Curaxon AG scores 72.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Curaxon AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Curaxon AG scores 1.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.1.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Curaxon AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Curaxon AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Curaxon AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Curaxon AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Curaxon AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rütistrasse 12
8955 Oetwil An Der Limmat

At a glance

Legal form
Corporation
UID
CHE-281.496.491
Founded
2020 · 6 years
Last commercial register change
April 28, 2020
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ET
    Endogena Therapeutics AG
    Zurich
    AI
    Acino International AG
    Zurich
    EP
    Eisai Pharma AG
    Zurich
    LP
    Leo Pharmaceutical Products Sarath Ltd
    Zürich
    NN
    Novo Nordisk Health Care AG
    Zürich
    NN
    Novo Nordisk Pharma AG
    Zürich
    TP
    Takeda Pharma AG
    Glattpark (Opfikon)
    VP
    Vifor Pharma Management AG
    Glattbrugg